BRAND NAME JUSTIFICATION SEAHORSE_Redacted.pdf
PDF 298 KB Posted
- Attached to
- AGILENT SEAHORSE XF FLEX ANALYZER SYSTEM Federal contract opportunity
- Solicitation number
- 36C26126Q0140
About this file
This document is a Single Source Justification for a Sole Source Award under the Simplified Acquisition Threshold (SAT) for the Department of Veterans Affairs. The Northern California VA Medical Center requires an Agilent Seahorse XF Flex Analyzer System for mitochondrial respiration and glycolysis analysis in translational oncology and immunometabolism research. The system includes an Agilent Seahorse XF Flex with Norm, XF Flex System, Seahorse XF Flex 3D Capture Flpk-L, Seahorse XF Cell Mito Stress Test Kit, and special handling and shipping, with a total estimated price redacted.
Market research confirmed that the Agilent Seahorse XF24 Flex is the only platform providing simultaneous, real-time measurement of mitochondrial respiration in a 24-well format compatible with patient-derived cells. A sources sought notice was posted on SAM.gov from 11/3/2025 through 11/7/2025, which identified multiple small business distributors including TEVET LLC, ACCUGOV, INC, and NETA SCIENTIFIC INC. The procurement will be a small business set-aside on the open market as a brand name only requirement, with the Country of Origin confirmed as United States (domestic).
View the file
Other files for this federal contract opportunity
| File | Type | Posted |
|---|---|---|
| 36C26126Q0140.pdf |
On GovTribe
Work with this file on GovTribe
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Single Source Justification for SAP under the SAT
Revision: 01 Effective Date: 11/15/2024 Page 2 of 2 Acquisition ID# part of standard practice in cellular metabolism, oncology, immunology, and toxicology research.
4. Description of market research conducted and results or statement why it was not conducted: Targeted market research was performed by VAMC staff and determine the Agilent Seahorse XF24 Flex is the most technically suitable and widely validated solution for VA research applications in cancer biology, immunotherapy response, and toxicant exposure modeling. This research included direct communication with multiple manufacturers and authorized distributors, review of published technical specifications, and evaluation of instrument capabilities relative to the specific research needs. Searches were conducted across FPDS for prior awards and identified sales directly to large business Original Equipment Manufacturer (OEM), Agilent Technologies Inc, as well as Small Business, Government Scientific Source Incorporated (GSS). Further review of GSA Advantage and GSA Elibrary pointed towards only reagents being available via GSA schedule through GSS. Market research outreaches were made to Agilent to determine authorized distributors, confirm Country of Origin (COO), and confirm the requirement would be open market. COO was confirmed as United States (domestic) and Agilent stated the necessary items and services are not available on contract. GSS was confirmed as an authorized distributor of Agilent. An outreach to GSS confirmed they are authorized to sell all necessary elements and services and that the requirement would be an open market purchase. A sources sought notice was posted to SAM.gov from 11/3/2025 through 11/7/2025 to identify if any additional small businesses sources existed. Responses were received from two small businesses and the Original Equipment Manufacturer (OEM). On 11/6/2025, the OEM confirmed there are multiple authorized distributors who qualify as small businesses in addition to GSS, including TEVET LLC, ACCUGOV, INC and NETA
SCIENTIFIC INC.
NMR restricts SDVOSB set aside but allows for a small business set aside as the rule of two has been met. This is a brand name only requirement where only the Agilent Seahorse XF24 Flex Extracellular Flux Analyzer will meet the required need.
With two or more small businesses known capable of meeting this requirement, this shall be solicited with small business set-aside on the open market as a brand name only requirement.
5. Contracting Officer's Certification: Purchase is approved in accordance with FAR13.106-1(b). I certify that the foregoing justification is accurate and complete to the best of my knowledge and belief.
Contracting Officer, Supply Team 2
File details come from the government source that posted it. Updated .